AI assistant
COMPUMEDICS LIMITED — Declaration of Voting Results & Voting Rights Announcements 2013
Oct 30, 2013
64672_rns_2013-10-30_0c7b39e6-d546-4f61-a968-71884c644397.pdf
Declaration of Voting Results & Voting Rights Announcements
Open in viewerOpens in your device viewer
ASX/Media Release 31 October 2013
==> picture [78 x 79] intentionally omitted <==
**Compumedics
Annual General Meeting Results**
Compumedics Limited (ASX: CMP) is pleased to provide results of its annual general meeting held today.
As part of that meeting the Company did change its auditors, with Ernst and Young retiring as auditors of the Company, following ASIC’s consent to such reitrement and Hayes Knight being appointed in their place.
**About
Compumedics**
Compumedics Limited was founded in 1987 by current Chairman/CEO Dr. David Burton and today is a global leader in the design and manufacture of diagnostic technologies for sleep disorders, neurophysiology and cardiology. In 1987 Compumedics established Asia Pacific's first fully computerized sleep laboratory. Compumedics holds 80% share of the Australian sleep-‐diagnostic market, and has a major and rapidly growing presence in the US, European and Asian marketplaces for its sleep, neurological, and Doppler blood-‐flow diagnostic monitoring devices. In 1995 the company was selected to supply equipment to the US Sleep Heart Health Study, the world's largest sleep study of its kind, with over 8,000 participants scheduled by 2008.
With headquarters in Melbourne, Australia and offices in the United States and Europe, its products are distributed in over 50 countries. In 1998 Compumedics was awarded the overall Australian Exporter of the Year. In 2000 Compumedics was listed on the Australian Stock Exchange. In 2002 , Compumedics acquired US-‐ based Neuroscan -‐ the world's leading supplier of instruments for brain research. In the US -‐ the world's largest medical device market -‐ Neuroscan holds around 90% of the market for brain-‐research products. In 2003 Compumedics was awarded the Frost & Sullivan Award for Market Expansion Strategy. In 2004 , Compumedics acquired Germany-‐based DWL Elektronishe GmbH, enabling Compumedics to expand its global operations into the neurovascular and cardio-‐vascular diagnostic fields. In 2006 , Compumedics was awarded the Frost and Sullivan Technology Leadership award for its innovative Somte® recorder product. In 2007 , Compumedics and its Chairman were inducted into the Victorian Manufacturing Hall of Fame. In 2008 the DWL division received a top 100 German Innovation award. With 20,000 systems installed globally across the finest hospital, universities and clinics Compumedics sales have grown more than 4-‐fold from $9 million (1999) to $39 million (2008). In 2009 Compumedics was awarded a design award for its GRAEL® PSG/EEG premium laboratory-‐based product. In 2010 Compumedics was recognized by the Australian Innovation Government and Industry body as one of Australia's Top 100 Health Innovators through its world leading devices for sleep diagnostics.
In 2011 Compumedics was selected as one of the 25 innovative Australian companies by the Australian Governments Department of Innovation, Industry, Science and Research (Industry).
For more information please visit: www.compumedics.com
**For
further information please contact:**
David Burton, Chairman and CEO Compumedics Limited T: (03) 8420 7300 M: 0414 384684 E: [email protected]
Rod North , Managing Director, Bourse Communications Pty Ltd T: (03) 9510 8309, M: 0408 670 706 E: [email protected]